3-((3-Iodoimidazo[1,2-b]pyridazin-6-yl)amino)propan-1-ol

Catalog No.: 
ACYDKT941
CAS No.: 
1803594-78-6
Molecular Formula: 
C9H11IN4O
Molecular Weight: 
318.12
3-((3-Iodoimidazo[1,2-b]pyridazin-6-yl)amino)propan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-((3-Iodoimidazo[1,2-b]pyridazin-6-yl)amino)propan-1-ol
IUPAC Name3-((3-iodoimidazo[1,2-b]pyridazin-6-yl)amino)propan-1-ol
MDL No.MFCD28954163
Molecular FormulaC9H11IN4O
Molecular Weight318.12
SMILESOCCCNC1=NN2C(C=C1)=NC=C2I
InChI KeyHBSRUZQOYDIOPM-UHFFFAOYSA-N
Synonym1-Propanol, 3-[(3-iodoimidazo[1,2-b]pyridazin-6-yl)amino]-;3-({3-Iodoimidazo[1,2-b]pyridazin-6-yl}amino)propan-1-ol
CAS No.1803594-78-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYDKT941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAIZV137 route compound structure diagram
    ACAIZV13714302-46-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYDKT941 route product structure diagram
    ACYDKT9411803594-78-6
Inquiry

2. ACYDKT941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYDKT941 route product structure diagram
    ACYDKT9411803594-78-6
Inquiry

3. ACYDKT941 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYDKT941 route product structure diagram
    ACYDKT9411803594-78-6
Inquiry

Comments (0)